🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, multi-center, randomized, phase III study. It is aim...
Status
Active Not Recruiting
Location
Guangdong Lung cancer institute
Start Date
2022-06-20
Trial ID
NCT04841811
Treatments Being Tested
Hepatocellular carcinoma (HCC) is a leading global cause of cancer-related ...
Status
Not Yet Recruiting
Location
Division of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2025-12-31
Trial ID
NCT07350824
Treatments Being Tested
This study dynamically monitored the prognosis of stage I-IV colorectal can...
Status
Active Not Recruiting
Location
Cancer hospital Chinese academy of medical sciences
Start Date
2022-06-20
Trial ID
NCT05444491
The goal of this interventional clinical trial is to compare the efficacy o...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-02-24
Trial ID
NCT07413146
This is a prospective, single-arm, exploratory study evaluating the combina...
Status
Recruiting
Location
Shenzhen University general hospital
Start Date
2026-04-21
Trial ID
NCT07563179
Treatments Being Tested
Multi-center observational clinical study to evaluate the application value...
Status
Unknown
Location
Parc de Salut Mar - Hospital del Mar
Start Date
2021-02-01
Trial ID
NCT05641870
This is a single-arm, interventional study to explore the feasibility of ci...
Status
Active Not Recruiting
Location
Qilu Hospital of Shandong Univertisy
Start Date
2023-10-01
Trial ID
NCT06157216
Treatments Being Tested
The purpose of this research study is to see if people whose Acute myeloid ...
Status
Recruiting
Location
Moffitt Cancer Center
Start Date
2024-11-07
Trial ID
NCT06511882
Treatments Being Tested
Ph-like ALL is a recently recognized high-risk subgroup and the optimal the...
Status
Unknown
Location
Department of Hematology, Nanfang Hospital
Start Date
2016-02-14
Trial ID
NCT03564470
The study will include newly-diagnosed AML patients, not suffering acute pr...
Status
Unknown
Location
Weill Cornell Medicine
Start Date
2017-07-03
Trial ID
NCT03257241
Treatments Being Tested